Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Grand River Aseptic Manufacturing Continues to Expand Capabilities with New, State-of-the-Art Colanar Syringe Filler

Grand River Aseptic Manufacturing,Inc.
Posted on: 06 Mar 18

Grand River Aseptic Manufacturing, Inc. (GRAM), a leading parenteral contract manufacturing organization, expands its capabilities in syringe filling at its FDA-inspected, cGMP-compliant manufacturing facility in Grand Rapids, Mich.

The Colanar FSV syringe filler will utilize the existing single-use systems already in place at GRAM and will support both small molecule APIs and biologics projects. The purchase is one of many capital investments being made by GRAM to foster client growth and enhance its capabilities.

The purchase of the syringe filler comes only months after the news of a partnership deal reached between GRAM and Arlington Capital Partners, a private equity firm based in Washington, D.C.

“With the support of Arlington, GRAM intends to invest heavily in building out our capabilities in the next couple of years with state-of-the-art equipment and a new facility. The new syringe filler is the first of many exciting announcements we will be making this year,” said Tom Ross, president and CEO of GRAM.

“The new syringe filler will expand our capabilities and demonstrates GRAM’s commitment to quality while advancing our core capabilities and technology,” stated Steve Nole, director of operations. “The Colonar FSV syringe filler, combined with our single-use system, will allow clients to expedite the time between project initiation and manufacture date.”

The syringe filler will be qualified and operational by the second quarter of this year. In addition to filling syringes, the new filler is capable of handling cartridges.

About Grand River Aseptic Manufacturing, Inc.
Grand River Aseptic Manufacturing, Inc. (GRAM), a parenteral contract manufacturing organization, delivers customized solutions to meet clients’ fill and finish needs from development through commercialization. With capabilities for biologics as well as controlled substances, GRAM’s expert project managers and modern facilities support pharmaceutical development and cGMP manufacturing, analytical testing and regulatory filing. For more information, visit grandriverasepticmfg.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180306005438/en/

Business Wire
www.businesswire.com

Last updated on: 06/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.